The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Abstract East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily pract...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thrombosis and haemostasis Ročník 121; číslo 4; s. 422 - 432
Hlavní autoři: Kim, Hyun Kuk, Tantry, Udaya S., Smith, Sidney C., Jeong, Myung Ho, Park, Seung-Jung, Kim, Moo Hyun, Lim, Do-Sun, Shin, Eun-Seok, Park, Duk-Woo, Huo, Yong, Chen, Shao-Liang, Bo, Zheng, Goto, Shinya, Kimura, Takeshi, Yasuda, Satoshi, Chen, Wen-Jone, Chan, Mark, Aradi, Daniel, Geisler, Tobias, Gorog, Diana A., Sibbing, Dirk, Lip, Gregory Y. H., Angiolillo, Dominick J., Gurbel, Paul A., Jeong, Young-Hoon
Médium: Journal Article
Jazyk:angličtina
Vydáno: Rüdigerstraße 14, 70469 Stuttgart, Germany Georg Thieme Verlag KG 01.04.2021
Témata:
Review Article
direct oral anticoagulants
bleeding risk
antiplatelet therapy
race
ischemic risk
ISSN:0340-6245, 2567-689X, 2567-689X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Abstract East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk–benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
ObjectType-Review-4
content type line 23
ISSN:0340-6245
2567-689X
2567-689X
DOI:10.1055/s-0040-1718729